SANA BIOTECHNOLOGY INC (SANA) Stock Analyst Ratings
USA - NASDAQ:SANA - US7995661045 - Common Stock
3.4 USD
-0.13 (-3.68%)
3.45 USD
+0.05 (+1.47%)
ChartMill assigns a Buy % Consensus number of 85% to SANA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.31. This target is 144.29% above the current price.
SANA was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SANA.
In the previous month the buy percentage consensus was at a similar level.
SANA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-30 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-09-24 | Wedbush | Initiate | Outperform |
| 2025-06-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | Citizens Capital Markets | Upgrade | Market Perform -> Market Outperform |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | Jefferies | Initiate | Buy |
| 2025-01-08 | TD Cowen | Upgrade | Hold -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-09 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-16 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-10-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-09-25 | JMP Securities | Initiate | Market Outperform |
| 2023-09-05 | Citigroup | Initiate | Buy |
| 2023-08-14 | TD Cowen | Initiate | Market Perform |
| 2023-05-02 | HC Wainwright & Co. | Initiate | Neutral |
| 2023-01-24 | Morgan Stanley | Maintains | Overweight |
| 2022-11-03 | Goldman Sachs | Maintains | Neutral |
| 2022-05-17 | Morgan Stanley | Maintains | Overweight |
| 2021-08-06 | Goldman Sachs | Maintains | Neutral |
SANA BIOTECHNOLOGY INC / SANA FAQ
What do analysts expect the price target to be for SANA BIOTECHNOLOGY INC (SANA)?
15 analysts have analysed SANA and the average price target is 8.31 USD. This implies a price increase of 144.29% is expected in the next year compared to the current price of 3.4.
What is the consensus rating for SANA BIOTECHNOLOGY INC (SANA) stock?
The consensus rating for SANA BIOTECHNOLOGY INC (SANA) is 85.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SANA BIOTECHNOLOGY INC (SANA)?
The number of analysts covering SANA BIOTECHNOLOGY INC (SANA) is 15.